RxDoctor Payments Data

Jacob Bailey

Physician Assistant · Omaha, NENPI 1659012508

Payments from drug & device makers

$4,797in general payments, 2019–2025

Across 271 payments — averaging $17.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$750
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$722
  • AbbVie$707
  • Alkermes, Inc.$591
  • Vanda Pharmaceuticals Inc.$418
  • Otsuka America Pharmaceutical, Inc.$312
  • plus $1K from 13 others

What the payments were for

  • Food & beverage$4,65797%
  • Education$1403%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,797 in reported general payments places this provider in the 90th percentile of 1,127 physician assistant providers in Nebraska.

See all physician assistant providers in Nebraska

Medicare billing

Part B allowed, 2024
$10,331
Medicare patients
44
Services billed
142

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
VraylarCariprazine Hcl24$37,150
CaplytaLumateperone Tosylate16$26,769
Aripiprazole49$7,843
Lurasidone Hcl17$4,871
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl36$3,650
Quetiapine Fumarate98$1,980
Venlafaxine Hcl ErVenlafaxine Hcl97$1,387
Divalproex Sodium ErDivalproex Sodium21$1,309
Trazodone Hcl115$1,184
Bupropion XlBupropion Hcl63$901
Haloperidol50$889
Hydroxyzine Hcl37$884
Olanzapine56$845
Risperidone89$833
Paliperidone ErPaliperidone12$731

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieVraylar$707$37,15024 claims
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta$722$26,76916 claims
Almatica Pharma LLCSertraline Hcl$192$36450 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,127 physician assistant providers in Nebraska.

Other physician assistant in Omaha

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →